AH
GMAB icon

Andreas Halvorsen’s Genmab GMAB Stock Holding History

Andreas Halvorsen’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-377,562
Closed -$15.4M – 109
2020
Q4 		$15.4M Sell
377,562
-842
-0.2% -$31.5K 0.04% 93
2020
Q3 		$13.9M Sell
378,404
-196,682
-34% -$7.11M 0.05% 85
2020
Q2 		$19.5M Sell
575,086
-265,899
-32% -$7.25M 0.08% 67
2020
Q1 		$17.8M Buy
840,985
+255,676
+44% +$5.7M 0.09% 59
2019
Q4 		$13.1M Sell
585,309
-7,657
-1% -$167K 0.06% 64
2019
Q3 		$12M Buy
+592,966
New +$11.7M 0.06% 59

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Andreas Halvorsen's GMAB Position: Q1 2021 in Review

Andreas Halvorsen sold out of Genmab (GMAB) in Q1 2021, closing a stake of 377,562 shares — an estimated $15.4M sold.

Andreas Halvorsen first reported a position in GMAB in Q3 2019 and held it in 6 quarters. The position peaked at $19.5M in Q2 2020. 210 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Andreas Halvorsen reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • Andreas Halvorsen sold 377,562 Genmab shares in Q1 2021, an estimated $15.4M.
  • Andreas Halvorsen first reported a position in Genmab in Q3 2019 and held it in 6 quarters.
  • Andreas Halvorsen's Genmab position peaked at $19.5M in Q2 2020.
  • 210 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Viking Global Investors's 13F filing for Q1 2021, filed 17 May 2021.